Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1659 of 6351
-
Heavy lifting may help cancer survivors rebuild strength
Symptom relief CompletedDespite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to…
Phase 2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Blood filtering showdown: can lower volume save young livers?
Disease control Recruiting nowAcute liver failure is a multisystem disorder characterized by a syndrome of jaundice, coagulopathy, and encephalopathy with high mortality in the absence of liver transplantation. The pathogenesis of multiorgan failure (MOF) in ALF has been attributed to the release of damage-as…
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a Mind-Body program ease knee pain and lift mood?
Symptom relief OngoingThe aim of this research study is to test the feasibility of a physical and mental health intervention (Positive Minds, Strong Joints or PMSJ) for Black adults with knee osteoarthritis (OA).
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New therapy aims to break the cycle of addiction and family violence in fathers
Disease control Recruiting nowThis study involves a randomized controlled trial of Fathers for Change (F4C) compared to Individual Drug Counseling (IDC) with a sample of 280 fathers enrolled in substance use (SU) treatment within community or veterans (VA) healthcare settings to (a) demonstrate F4C efficacy c…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Magnetic helmet trial aims to slow deadly brain tumors
Disease control Recruiting nowThe clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.
Sponsor: BioTex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New study aims to ease depression and anxiety in expecting and new mothers
Symptom relief Recruiting nowPerinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interv…
Sponsor: Kenyatta National Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Weekly insulin shot could replace daily injections for diabetes
Disease control OngoingThis study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Glargine U100 with Non-Insulin Antidiabetic Agents in Insulin-naive Subjects with Type 2 Diabetes Mellitusin.
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowVIA Disc NP is a non-surgical intervention intended to supplement nucleus pulposus tissue in degenerated intervertebral discs. This is a randomized, sham-controlled, multi-center, double-blind clinical trial with an open label roll-in period of one participant per site in which …
Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Liver cancer drug trial halted early – what we know so far
Disease control Stopped earlyThis study aims to compare the safety and tolerability of cadonilimab applied after curative hepatectomy for hepatocellular carcinoma combined with high - risk recurrent factors.
Phase 2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can online coaching empower parents of children with autism?
Symptom relief CompletedFamilies of children with autism in Palestine may have difficulty accessing early intervention and rehabilitation services because specialized services are limited and families may face geographical, financial, and other barriers. Providing support to parents remotely may help fa…
Sponsor: Arab American University (Palestine) • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New community effort aims to slash HPV risk in nigerian families
Prevention OngoingThe present study expands on the investigators' earlier pilot study, outlined in ClinicalTrial ID#: NCT06010108. The Actions for Collaborative Community-Engaged Strategies for HPV (ACCESS-HPV), locally referred to as 4 Girls and Women (4GW) in Nigeria, seek to utilize a participa…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Weekly insulin shot could replace daily jabs for diabetes
Disease control OngoingThis study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Degludec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Scientists test pill to turn back the clock on aging
Disease control OngoingAging can be defined as a time-dependent functional decline in physiological function, which may increase the vulnerability to diseases and eventually death. The question is whether aging is a normal process, or exists as an "uber-illness?" Work done by Dr Sinclair at Harvard sug…
Early phase 1 • Sponsor: The Christ Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a simple drink fix a complication of cancer surgery?
Disease control CompletedThe goal of this clinical trial is to assess the effectiveness of oral iohexol in the treatment of postoperative chylous ascites. It will also learn about the safety of oral iohexol. The main questions it aims to answer are: * Confirm the potential of oral iohexol as an innovati…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can meditation curb loneliness in old age?
Symptom relief OngoingThe goal of this experimental study is to assess whether a mindfulness-based meditation intervention can reduce loneliness and improve psychophysical well-being in older adults (aged 65 and above). The main questions it aims to answer are: * Does the intervention reduce the per…
Sponsor: University of Pavia • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a voice-based program empower blind women through menopause?
Knowledge-focused CompletedThis randomized controlled trial was conducted to evaluate the effect of an audio-described menopause education program on menopause knowledge and menopausal symptoms in women with visual impairment. A total of 46 women who were members of the Ankara Branch of the Altı Nokta Blin…
Sponsor: Ankara University • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can going home sooner after Weight-Loss surgery save money without sacrificing safety?
Knowledge-focused Recruiting nowBariatric surgery is the most effective treatment for severe obesity and its associated diseases. Advances in surgical techniques, enhanced recovery protocols, and multimodal perioperative care have made earlier hospital discharge possible while maintaining patient safety. This …
Sponsor: Corporacion Parc Tauli • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Mushroom blend may tame menopause symptoms — trial puts it to the test
Symptom relief CompletedThis single-center, single-group, open-label study evaluated changes in menopause-related quality of life and menopausal symptoms in postmenopausal women aged 40 to 60 years after 24 weeks of treatment with HIFAS MENOPAUSE. Participants took two capsules of HIFAS MENOPAUSE orall…
Sponsor: Hifas da Terra S.L. • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Gentler chemo dose offers hope for frail breast cancer patients
Disease control Recruiting nowThis is a phase II study aiming at evaluating capecitabine prospectively at a dose of 1000 mg once daily in patients with advanced breast cancer who are ≥60 years of age, or frail at any age, with a greater risk of complications and poorer outcomes with other treatments.
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Money and marriage: new malawi study targets heavy drinking in HIV couples
Disease control Recruiting nowWith a full-scale randomized control trial, the investigators will evaluate the efficacy and cost effectiveness of Mlambe, an economic and relationship-strengthening intervention that provides incentivized saving accounts, financial literacy training, and relationship skills educ…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC